• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Learn Why The Bull Case For Perrigo Stock Could Change Following Weaker 2026 Guidance

    Simply Wall St·11/06/2026 03:44:10
    Listen to the news
    • Perrigo Company plc reported third quarter 2026 sales of US$988.6 million and a net loss of US$27.5 million, and outlined weaker full year 2026 guidance alongside the planned treatment of its infant formula divestiture as discontinued operations.
    • The divestiture of the infant formula unit and a guided year on year net sales decline of 4.6% to 5.7% point to a sharper focus on core over the counter health products, although this brings nearer term revenue pressure.
    • We will now look at how Perrigo's investment narrative could shift in light of the deeper 2026 sales guidance cut.
    Spot under-pressure healthcare stories like Perrigo alongside other potential turnaround candidates with resilient balance sheets in our hand picked list of solid balance sheet and fundamentals (25 results).

    Perrigo Investment Narrative Recap

    To own Perrigo, you need to believe the consumer self care pivot can offset current pressure on demand and pricing. In the near term, the story revolves around stabilising core OTC categories after the infant formula sale and translating market share gains into steadier revenue. The weaker 2026 net sales outlook puts more weight on execution of that refocus.

    The key short term catalyst is whether Perrigo can turn those share gains and cost programs into cleaner margins despite softer U.S. and European consumption. The biggest risk is that volume driven private label exposure and ongoing category weakness could keep sales drifting lower while the business remains loss making.

    The clearest development tied to this thesis is the new 2026 guidance, which calls for all in net sales to decline 4.6% to 5.7%. That update, paired with a US$27.5 million quarterly loss and a US$351.6 million loss for the first nine months of 2026, keeps investors focused on the path to consistent profitability.

    The revised outlook follows the infant formula divestiture and reflects retailer inventory patterns and a softer European consumer backdrop. Those factors directly affect the timing of any potential earnings recovery catalyst. At the same time, the US$0.29 quarterly dividend, recently affirmed for December, draws attention to dividend coverage as a live risk while cash generation remains under pressure.

    Perrigo's current earnings sit at a loss of US$1.7b, while analysts forecast earnings of US$86.4 million on revenues of US$4.2b by 2029. This implies a very large earnings improvement in dollar terms as profit margins are expected to move from a loss-making 41.1% today to a positive 2.0%, with revenue described as remaining fairly flat over that period.

    Uncover why Perrigo's fair value indicates a 15% potential upside to its current price, which could narrow quickly.

    NYSE:PRGO 1-Year Stock Price Chart
    NYSE:PRGO 1-Year Stock Price Chart

    Exploring Other Perspectives

    For a very different angle, some of the most optimistic analysts were leaning hard on Perrigo’s cost savings story. Before this weaker 2026 guidance, they were pencilling in revenue of about US$4.2b and earnings near US$131.9 million by 2029. You should expect those views to evolve and compare these upbeat assumptions with your own.

    Explore 3 other Perrigo fair value estimates, including one that suggests as much as 156% upside from the current price!

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Looking for more investment ideas beyond Perrigo?

    If Perrigo has sharpened your focus on balance sheets, earnings quality, and realistic expectations, it can be useful to set it alongside a wider watchlist built around the traits you care about most.

    • If capital protection comes first for you, start by scanning 32 resilient stocks with low risk scores that keep risk scores in check while still offering equity upside.
    • If you want income to matter as much as price charts, sort through 6 dividend fortresses that pair 5%+ yields with an emphasis on resilience.
    • If you prefer to hunt earlier in the story rather than after the crowd arrives, narrow your search with 21 high quality undiscovered gems that combine strong fundamentals with lower market attention.